| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |